← Back to Search

Quit2Heal App for Smoking Cessation in Cancer Patients

Phase 3

Waitlist Available

Led By Jonathan Bricker

Research Sponsored by Fred Hutchinson Cancer Research Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 or older

Diagnosed with cancer within the past 24 months or currently receiving or planning to receive cancer treatment in the next 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3 months after randomization

Awards & highlights

No Placebo-Only Group

Pivotal Trial

Summary

This trial is testing whether the Quit2Heal app is more effective than the QuitGuide app in helping cancer patients quit smoking.

Who is the study for?

This trial is for adults over 18 in the US who have been diagnosed with cancer within the last two years or are undergoing treatment. Participants must be current smokers interested in quitting, willing to use a smartphone app for cessation, and able to complete surveys. They should not be using other quit-smoking programs or have used NCI's QuitGuide app.

What is being tested?

The study compares two smoking cessation apps: Quit2Heal and QuitGuide. Both offer strategies to handle cravings, guides on quitting, staying smoke-free plans, and advice on choosing medications that help stop smoking. Patients will randomly receive one of these apps.

What are the potential side effects?

Since this trial involves the use of smartphone applications rather than medication, there are no direct medical side effects associated with participation. However, participants may experience stress or frustration related to quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I was diagnosed with cancer in the last 2 years or will start treatment soon.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3 months after randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3 months after randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months after randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of participants with 30-day cigarette smoking cessation at 12 months.

Secondary study objectives

Number of participants with 30-day cigarette smoking cessation at 3 months.

Number of participants with 30-day cigarette smoking cessation at 6 months.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Pivotal Trial

The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (Quit2Heal app)Experimental Treatment2 Interventions

Patients receive the Quit2Heal app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.

Group II: Arm II (QuitGuide app)Active Control2 Interventions

Patients receive the QuitGuide app and are encouraged to use it frequently. During the entire 12-month follow-up period, the app will remain fully available anytime study participants wish to use it.

0 / 2Eligibility criteria met